isoxazoles has been researched along with Substance Withdrawal Syndrome in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Akinola, LS; Alkhlaif, Y; Bautista, MR; Carper, M; Chen, YC; Damaj, MI; Fowler, CD; Garai, S; Hamouda, AK; Jackson, A; Thakur, GA; Toma, WB | 1 |
| Dunn, KE; Kim, C; Marcus, TF; Schroeder, JR; Umbricht, A; Vandrey, R | 1 |
| Eglin, M; Hajak, G; Hedner, J; Loft, H; Lundahl, J; Lütolf, S; Stórustovu, SI | 1 |
| Chang, JP; Huang, CC; Su, KP | 1 |
| Alamo, C; Ferre, F; Jiménez-Arriero, MÁ; López-Muñoz, F; Martínez-Gras, I; Pascual, JM; Ponce, G; Rubio, G | 1 |
| Huang, YC; Liang, CS; Yang, FW | 1 |
| Campistol, J; Darling, A; Perez-Duenas, B; Poo, P | 1 |
| Gong, QH; Gulinello, M; Smith, SS | 1 |
| Cagetti, E; Liang, J; Olsen, RW; Spigelman, I | 1 |
| Breese, GR; Frye, GD; McCown, TJ | 1 |
| Dalby, JT; Dickson, R; Williams, R | 1 |
| Byerly, MJ; Evans, DL; Greer, RA | 1 |
| Zimbroff, DL | 1 |
| Cott, J; Lieberman, JA; Matthews, S; Shore, D | 1 |
| Arneric, SP; Brioni, JD; Buckley, MJ; Decker, MW; Kim, DJ; O'Neill, AB | 1 |
| Zharkovskaia, TA; Zharkovskiĭ, AM | 1 |
1 review(s) available for isoxazoles and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid | 2013 |
3 trial(s) available for isoxazoles and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.
Topics: Adult; Humans; Isoxazoles; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Zonisamide | 2016 |
A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Electronic Data Processing; Female; GABA Agonists; Humans; Isoxazoles; Male; Middle Aged; Pyridines; Severity of Illness Index; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult; Zolpidem | 2009 |
Zonisamide versus diazepam in the treatment of alcohol withdrawal syndrome.
Topics: Adult; Alcoholism; Anticonvulsants; Diazepam; Dose-Response Relationship, Drug; Ethanol; Female; Humans; Isoxazoles; Male; Middle Aged; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult; Zonisamide | 2010 |
12 other study(ies) available for isoxazoles and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
Topics: Allosteric Regulation; Animals; Behavior, Animal; Hydrocarbons, Brominated; Indole Alkaloids; Isoxazoles; Mice; Nicotine; Nicotinic Agonists; Protein Isoforms; Pyrazoles; Receptors, Nicotinic; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2021 |
Paliperidone overdose in a patient with schizophrenia.
Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Schizophrenia; Substance Withdrawal Syndrome | 2010 |
Rabbit syndrome following discontinuation of paliperidone in a patient with schizoaffective disorder.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Parkinsonian Disorders; Psychotic Disorders; Pyrimidines; Substance Withdrawal Syndrome; Syndrome | 2012 |
Progesterone withdrawal increases the anxiolytic actions of gaboxadol: role of alpha4betadelta GABA(A) receptors.
Topics: Animals; Anti-Anxiety Agents; Drug Implants; Female; GABA Agonists; Hippocampus; Ion Channels; Isoxazoles; Maze Learning; Pentobarbital; Premenstrual Syndrome; Progesterone; Protein Isoforms; Protein Subunits; Rats; Receptors, GABA-A; Substance Withdrawal Syndrome | 2003 |
Altered pharmacology of synaptic and extrasynaptic GABAA receptors on CA1 hippocampal neurons is consistent with subunit changes in a model of alcohol withdrawal and dependence.
Topics: Alcoholism; Animals; Azides; Benzodiazepines; Diazepam; Drug Interactions; Ethanol; GABA Agonists; Hippocampus; Isoxazoles; Neurons; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Substance Withdrawal Syndrome; Zolpidem | 2004 |
Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors.
Topics: 4-Aminobutyrate Transaminase; Acoustic Stimulation; Aminobutyrates; Animals; Chlordiazepoxide; Disease Susceptibility; Ethanol; Forelimb; gamma-Aminobutyric Acid; Humans; Isoxazoles; Male; Muscimol; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, GABA-A; Seizures; Substance Withdrawal Syndrome; Tremor | 1983 |
Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
Topics: Adult; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Dystonia; Humans; Isoxazoles; Male; Neurologic Examination; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome | 1994 |
Behavioral stimulation associated with risperidone initiation.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Anxiety; Benzodiazepines; Confusion; Female; Humans; Isoxazoles; Middle Aged; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome | 1995 |
Switching patients from clozapine to risperidone therapy.
Topics: Antipsychotic Agents; Clonazepam; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoxazoles; Lorazepam; Piperidines; Risperidone; Schizophrenia; Substance Withdrawal Syndrome | 1995 |
Clinical implications of clozapine discontinuation: report of an NIMH workshop.
Topics: Antipsychotic Agents; Clozapine; Drug Administration Schedule; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; United States; United States Food and Drug Administration | 1995 |
Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Cognition Disorders; Diazepam; Isoxazoles; Male; Maze Learning; Mecamylamine; Mice; Nicotine; Pyrrolidines; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1994 |
[Antiabstinent action of fenibut and baclofen on a model of abstinence induced by the benzodiazepine receptor antagonist CGS 8216 in rats receiving diazepam].
Topics: Animals; Baclofen; Behavior, Animal; Diazepam; Drug Evaluation, Preclinical; gamma-Aminobutyric Acid; Isoxazoles; Male; Pyrazoles; Rats; Receptors, GABA-A; Substance Withdrawal Syndrome; Tranquilizing Agents | 1987 |